Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One BiopharmaNews DeskMarch 6, 20260 Servier is expanding its cancer drug prospects through the $2.5 billion acquisition of Day One Biopharmaceuticals, a biotech with a…